First Time Loading...

Nektar Therapeutics
NASDAQ:NKTR

Watchlist Manager
Nektar Therapeutics Logo
Nektar Therapeutics
NASDAQ:NKTR
Watchlist
Price: 1.27 USD 0.79% Market Closed
Updated: Jun 1, 2024

Nektar Therapeutics
Short-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Nektar Therapeutics
Short-Term Debt Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Short-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Nektar Therapeutics
NASDAQ:NKTR
Short-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Short-Term Debt
$6.3B
CAGR 3-Years
176%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bristol-Myers Squibb Co
NYSE:BMY
Short-Term Debt
$3.3B
CAGR 3-Years
129%
CAGR 5-Years
54%
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Short-Term Debt
$7.2B
CAGR 3-Years
120%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Short-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Eli Lilly and Co
NYSE:LLY
Short-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Nektar Therapeutics's Short-Term Debt?
Short-Term Debt
0 USD

Based on the financial report for Mar 31, 2024, Nektar Therapeutics's Short-Term Debt amounts to 0 USD.